ProSomnus gets FDA nod for latest sleep apnea therapy device
April 13, 2026
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
Used with Beckman’s immunoassay analysers, MeMed’s BV test has been demonstrated to reduce unnecessary antibiotic use.
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents.
Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability
Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump.
CorTec’s BCI aims to differentiate itself by offering brain-based communication alongside therapeutic neurostimulation.
Cardiovascular diseases remain the leading cause of death worldwide, accounting for nearly 20 million deaths each year. Rapid diagnosis and risk assessment of cardiac injury are therefore essential for improving patient outcomes.
Scientists have found new genetic causes for diabetes in babies—in a part of the genome that has historically been overlooked in genetic studies.
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its potential as a therapeutic target, according to a recent study published in Nature Communications.
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different life-threatening autoimmune diseases that had resisted years of treatment.